Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank56
3Y CAGR+10.1%
5Y CAGR+0.1%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+10.1%/yr
vs -8.0%/yr prior
5Y CAGR
+0.1%/yr
Recent acceleration
Acceleration
+18.2pp
Accelerating
Percentile
P56
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineNormalizing
PeriodValueYoY Change
202513.32-12.5%
202415.22-17.4%
202318.42+84.7%
20229.97-40.0%
202116.63+25.5%
202013.26+24.9%
201910.62-23.9%
201813.95+10.0%
201712.68+169.1%
20164.71-